companiesCompany
Navignostics
Navignostics maps dozens of proteins at single-cell resolution across one tumour section, showing which cells sit next to which immune cells, to guide personalised treatment.
Overview
Navignostics, a Zürich company, combines highly multiplexed tumour imaging with data analytics: spatial single-cell proteomic analysis of a single formalin-fixed section captures tumour and immune cell types and their interactions. Future of Cancer Care Today lists it for both molecular and immune profiling, physician-ordered through an early-access partner programme.
Similar pages
not linked directly; found by shared links- CompanyVicinity Bio
Shares Multiplex immunofluorescence, Spatial transcriptomics and the tag fcct-directory.
- TechnologySingle-cell & spatial profiling